Morphine sulfate
- Product NDC
- 0228-3117
- 11-digit product format
- 002283117
- Labeler code
- 0228
- Product ID
- 0228-3117_d41b3be8-7ef7-4b1d-9692-fffd13baf96d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Morphine sulfate
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA079040
- Marketing category
- ANDA
- Marketing start
- 2014-02-04
- Substance
- MORPHINE SULFATE
- Active strength
- 75 mg/1
- Pharmacologic classes
- Full Opioid Agonists [MoA], Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Morphine sulfate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| MORPHINE SULFATE | 75 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | X3P646A2J0 |
| Rxcui | 892297, 892342, 892349, 892355, 894942, 894970 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0228-3117-11 | Morphine sulfate | 100 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 100 | | 47 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| MORPHINE SULFATE | ACTIVE INGREDIENT | X3P646A2J0 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| MORPHINE | ACTIVE MOIETY | 76I7G6D29C | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| ALCOHOL | INACTIVE INGREDIENT | 3K9958V90M | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| AMMONIA | INACTIVE INGREDIENT | 5138Q19F1X | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| BUTYL ALCOHOL | INACTIVE INGREDIENT | 8PJ61P6TS3 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| DIETHYL PHTHALATE | INACTIVE INGREDIENT | UF064M00AF | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| ETHYLCELLULOSES | INACTIVE INGREDIENT | 7Z8S9VYZ4B | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FD&C GREEN NO. 3 | INACTIVE INGREDIENT | 3P3ONR6O1S | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FD&C RED NO. 3 | INACTIVE INGREDIENT | PN2ZH5LOQY | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FERRIC OXIDE YELLOW | INACTIVE INGREDIENT | EX438O2MRT | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| HYDROXYPROPYL CELLULOSE (TYPE H) | INACTIVE INGREDIENT | RFW2ET671P | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| ISOPROPYL ALCOHOL | INACTIVE INGREDIENT | ND2M416302 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | INACTIVE INGREDIENT | 74G4R6TH13 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 18 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0228-3117 | MORPHINE SULFATE CAPSULE, EXTENDED RELEASE [ACTAVIS PHARMA, INC.] | 43 | Current NDC, Legacy NDC, 1 package rows | 20250418_2da87bfa-11fd-43e3-8fef-d16ebeb15680.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0228-3117-11 | 00228311711 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3117-11) | 2014-02-04 | 0000-00-00 | No | No | Current |